![]() |
UMIN-CTR Clinical Trial |
|
![]() |
![]() |
![]() |
![]() |
Name: | UMIN ID: |
Recruitment status | No longer recruiting |
Unique ID issued by UMIN | UMIN000030742 |
Receipt No. | R000035103 |
Scientific Title | Efficacy and safety of ripasudil hydrochloride in glaucoma patients being treated by prostaglandin analogues, but their intraocular pressures are 15mmHg or under. |
Date of disclosure of the study information | 2018/01/18 |
Last modified on | 2020/11/04 |
Basic information | ||
Public title | Efficacy and safety of ripasudil hydrochloride in glaucoma patients being treated by prostaglandin analogues, but their intraocular pressures are 15mmHg or under. | |
Acronym | Efficacy and safety of ripasudil hydrochloride in glaucoma patients being treated by prostaglandin analogues, but their intraocular pressures are 15mmHg or under. | |
Scientific Title | Efficacy and safety of ripasudil hydrochloride in glaucoma patients being treated by prostaglandin analogues, but their intraocular pressures are 15mmHg or under. | |
Scientific Title:Acronym | Efficacy and safety of ripasudil hydrochloride in glaucoma patients being treated by prostaglandin analogues, but their intraocular pressures are 15mmHg or under. | |
Region |
|
Condition | ||
Condition | glaucoma | |
Classification by specialty |
|
|
Classification by malignancy | Others | |
Genomic information | NO |
Objectives | |
Narrative objectives1 | To investigate the efficacy and safety of ripasudil hydrochloride in glaucoma patients in case of insufficiently IOP control by prostaglandin-related drug monotherapy although their IOPs are 15mmHg or under. |
Basic objectives2 | Safety,Efficacy |
Basic objectives -Others | |
Trial characteristics_1 | |
Trial characteristics_2 | |
Developmental phase |
Assessment | |
Primary outcomes | Comparison of intraocular pressure between at baseline (week 0) and at follow-up period (week 12) |
Key secondary outcomes | 1. Change of intraocular pressure in the study eye at the same time of week 4 from baseline (week 0)
2. Achievement rate of -20% or -30% intraocular pressure reduction in the study eye at the same time of week 12 from baseline (week 0) 3. Difference of intraocular pressure reduction between the study eye and non-treated eye at the same time of week 12 from baseline (week 0) 4. Difference of intraocular pressure reduction between the study eye and non-treated eye at the same time of week 4 from baseline (week 0) 5. Change of indexes listed below at the study eye at the same time of week 12 from baseline (week 0) 6. Change of indexes listed below at the study eye at the same time of week 4 from baseline (week 0) 7. Differences of indexes listed below between the study eye and non-treated eye at the same time of week 12 from baseline (week 0) 8. Differences of indexes listed below between the study eye and non-treated eye at the same time of week 4 from baseline (week 0) 9. Change of difference between the study eye and non-treated eye from baseline to week 12 10. Frequency of adverse events and adverse reactions <indexes> intraocular pressure measured by Goldmann applanation tonometer visual acuity gonioscopy test slit lamp microscope test fundus test history of prostaglandin-related drug treatment |
Base | |
Study type | Observational |
Study design | |
Basic design | |
Randomization | |
Randomization unit | |
Blinding | |
Control | |
Stratification | |
Dynamic allocation | |
Institution consideration | |
Blocking | |
Concealment |
Intervention | |
No. of arms | |
Purpose of intervention | |
Type of intervention | |
Interventions/Control_1 | |
Interventions/Control_2 | |
Interventions/Control_3 | |
Interventions/Control_4 | |
Interventions/Control_5 | |
Interventions/Control_6 | |
Interventions/Control_7 | |
Interventions/Control_8 | |
Interventions/Control_9 | |
Interventions/Control_10 |
Eligibility | ||||
Age-lower limit |
|
|||
Age-upper limit |
|
|||
Gender | Male and Female | |||
Key inclusion criteria | Patients who meet all of the following criteria are included in this study.
1. One prostaglandin-related drug did not provide sufficient reduction in intraocular pressure, and after December 2017, at the discretion of the attending physician, additional glaucoma treatment with ripasudil hydrochloride was required or will be performed Glaucoma patients in the future. 2. Intraocular pressure of both eyes are 15mmHg or lower at their consent and week 0, and difference of intraocular pressure at their consent and at the latest consultation before the consent is 2mmHg or lower. 3. Male and female patients aged 20 years or older and younger than 75 years when giving their consent. 4. Patients who can give their consent in a written form |
|||
Key exclusion criteria | Patients who fall into any of the following criteria are excluded from participating in the study.
1. Patients with a contraindicated condition to use the study drug 2. Patients who are breastfeeding, pregnant, or parturient 3. Patients whose best-corrected visual acuity is less than 0.5 4. Patients whose spherical equivalent is less than -0.9D or +0.9 or higher 5. Patients in whom the difference of spherical equivalent between both eyes is 3D or higher 6. Patients whose intraocular pressure can not be correctly measured by Goldmann applanation tonometer 7. Patients whose mydriasis is insufficient and in whom the observation of the optic nerve head is impossible 8. Patients with history of invasive eye surgery or laser treatment, except cataract surgery within 6 months 9. Patients with eye trauma 10. Patients with complication of retina disease which affect visual field 11. Patients with optic nerve disease or intracranial disease which affect visual field 12. Patients with other conditions that the investigator/researcher thinks inappropriate for the study |
|||
Target sample size | 30 |
Research contact person | |||||||
Name of lead principal investigator |
|
||||||
Organization | Yotsuya Shirato Ophthalmology Clinic | ||||||
Division name | Ophthalmology | ||||||
Zip code | |||||||
Address | Yotsuya Mitsuke building 3F, 1-1, Yotsuya, Shinjyuku, Tokyo, Japan | ||||||
TEL | 03-3355-4281 | ||||||
shirato-eye-clinic@vanilla.ocn.ne.jp |
Public contact | |||||||
Name of contact person |
|
||||||
Organization | Soiken Inc. | ||||||
Division name | Clinical Study Support Division | ||||||
Zip code | |||||||
Address | NBF Ogawamachi Building 4F, 1-3-1 Ogawamachi, Kanda, Chiyoda-ku, Tokyo | ||||||
TEL | 03-3295-1350 | ||||||
Homepage URL | |||||||
takayama@soiken.com |
Sponsor | |
Institute | Yotsuya Shirato Ophthalmology Clinic |
Institute | |
Department |
Funding Source | |
Organization | Kowa Company, Ltd. |
Organization | |
Division | |
Category of Funding Organization | Profit organization |
Nationality of Funding Organization |
Other related organizations | |
Co-sponsor | |
Name of secondary funder(s) |
IRB Contact (For public release) | |
Organization | |
Address | |
Tel | |
Secondary IDs | |
Secondary IDs | NO |
Study ID_1 | |
Org. issuing International ID_1 | |
Study ID_2 | |
Org. issuing International ID_2 | |
IND to MHLW |
Institutions | |
Institutions |
Other administrative information | |||||||
Date of disclosure of the study information |
|
Related information | |
URL releasing protocol | |
Publication of results | Unpublished |
Result | |
URL related to results and publications | |
Number of participants that the trial has enrolled | |
Results | |
Results date posted | |
Results Delayed | |
Results Delay Reason | |
Date of the first journal publication of results | |
Baseline Characteristics | |
Participant flow | |
Adverse events | |
Outcome measures | |
Plan to share IPD | |
IPD sharing Plan description |
Progress | |||||||
Recruitment status | No longer recruiting | ||||||
Date of protocol fixation |
|
||||||
Date of IRB |
|
||||||
Anticipated trial start date |
|
||||||
Last follow-up date |
|
||||||
Date of closure to data entry | |||||||
Date trial data considered complete | |||||||
Date analysis concluded |
Other | |
Other related information | none |
Management information | |||||||
Registered date |
|
||||||
Last modified on |
|
Link to view the page | |
URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000035103 |
Research Plan | |
Registered date | File name |
Research case data specifications | |
Registered date | File name |
Research case data | |
Registered date | File name |